Esperer Onco Nutrition Private Limited - Company Profile

It is a healthcare private limited company based in Navi Mumbai, Maharashtra, India, established in 2019.

2019 Navi Mumbai, Maharashtra, India Active

Last Updated: February 08, 2026

About Esperer Onco Nutrition Private Limited

Esperer Onco Nutrition Private Limited, a active private limited company, was established on 14 March 2019 in Navi Mumbai, Maharashtra, India. Engaging in preventive health supplements within the trade sector, it holds CIN: U24299MH2019PTC322571. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.37 Cr and a paid-up capital of ₹3.03 Cr.

Employing 18 professional, Its leadership includes Sudipta Chattopadhyay (Director), Sohilkumar Dahyabhai Tandel (Director), Raktim Chattopadhyay (Director). Past directors included Sudipta Chattopadhyay, Shivshankar Gangaram Bangar, Arun Dubey. It holds ₹1.06 M open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No 170, Plot No 19, Sector 19D, Satra Plaza, Vashi, Navi Mumbai, Maharashtra, 400705.

Company Details

CIN/LLPIN
U24299MH2019PTC322571
Registration Number
322571
Incorporation Date
14 March 2019
Authorized Capital
₹3.37 Cr
Paid-Up Capital
₹3.03 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.37 Cr as on 08-02-2026
Paid Up Capital ₹ 3.03 Cr as on 08-02-2026
Company Age 6 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 1.06 M as on 08-02-2026
Satisfied Charges ₹ 1.00 Cr as on 08-02-2026
Revenue Growth **** 360.11% (FY 2022)
Profit Growth **** -13.41% (FY 2022)
Ebitda **** -82.95% (FY 2022)
Net Worth 80.91% (FY 2022)
Total Assets **** 144.90% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Esperer Onco Nutrition Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Esperer Onco Nutrition Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sudipta Chattopadhyay	Director	20 Dec 2023	Current
Sohilkumar Dahyabhai Tandel	Director	08 Aug 2024	Current
Raktim Chattopadhyay	Director	14 Mar 2019	Current
Riddhesh Neema	Director	20 Dec 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Director	09 Apr 2020	Past
Pramod Abcsdd	Nominee Director	20 Dec 2023	Past
Pramod Abcsdd	Director	02 Apr 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Esperer Onco Nutrition.

Esperer Onco Nutrition Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 360.11% increase. The company also saw a substantial fall in profitability, with a 13.41% decrease in profit. The company's net worth Soared by an impressive increase of 80.91%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

360.11%

*******

Revenue from Operations

*******

396.43%

*******

Total Assets

*******

144.90%

*******

Profit or Loss

*******

-13.41%

*******

Net Worth

*******

80.91%

*******

EBITDA

*******

-82.95%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Esperer Onco Nutrition?

In 2023, Esperer Onco Nutrition had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,064,000.00

Satisfied Charges

₹10,000,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 0.11 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 May 2025	Hdfc Bank Limited	₹1.06 M	Open
14 Jul 2021	Others	₹1.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Esperer Onco Nutrition?

Esperer Onco Nutrition has a workforce of 18 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Esperer Onco Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esperer Onco Nutrition's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Esperer Onco Nutrition

Recent Activity within the Organization

Annual General Meeting

Esperer Onco Nutrition Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 101127909 was registered on 17 May 2025. was completed.
17 May 2025
Balance Sheet

Esperer Onco Nutrition Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Riddhesh Neema was appointed as a Director was appointed as a Director on 20 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
20 Dec 2024
Charges

The activity A charge registered on 14 Jul 2021 via Charge ID 100459523 with Others was fully satisfied on 26 Nov 2024. was completed.
26 Nov 2024
Director Appointment

The activity Sohilkumar Dahyabhai Tandel was appointed as a Director was appointed as a Director on 08 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.
08 Aug 2024

Explore recent activity and updates - View Recent Activity